MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Journal of Clinical Oncology
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

9,514 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
9,514 works in the cohort · of 4,299,418page 50 of 191

Labels cover 106 of 9,514 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 9,514 of 9,514 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
The Ethics of Early Stopping Rules
Joseph L. Pater, Paul E. Goss, Jame Ingle, Wendy Shelley, Lois E. Shepherd
2005· letter· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · metaresearch+research_integrityconsensus · none
11
citations
afffundno abstractunlabeled
Ethical and Policy Issues for Seamless Phase I Oncology Trials
Nora Hutchinson, Esther Vinarov, Alexia Iasonos, Jonathan Kimmelman
2019· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · metaresearch+research_integrityconsensus · none
11
citations
affaboutunlabeled
Treatment sequencing in MPC, insights from a 3˚ care center.
Ivan Barrera, Jill J. Ranger, Nooshin Roofigari, Richard Dalfen, Gerald Batist, Petr Kavan
2019· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations
affaboutunlabeled
The Choosing Wisely Canada cancer initiative.
Gunita Mitera, Andrea Bezjak, Christopher M. Booth, Guila Delouya, Christine Desbiens, Craig C. Earle +5 more
2014· article· en· Journal of Clinical Oncology· Economics, Econometrics and Finance
machine prediction:candidate · noneconsensus · none
11
citations
affunlabeled
Treatment-free survival (TFS) after discontinuation of first-line nivolumab (NIVO) plus ipilimumab (IPI) or sunitinib (SUN) in intention-to-treat (ITT) and IMDC favorable-risk patients (pts) with advanced renal cell carcinoma (aRCC) from CheckMate 214.
David F. McDermott, Brian I. Rini, Robert J. Motzer, Nizar M. Tannir, Bernard Escudier, Christian Kollmannsberger +14 more
2019· article· en· Journal of Clinical Oncology· Medicine
machine prediction:candidate · noneconsensus · none
11
citations
affunlabeled
Optima: Optimal personalised treatment of early breast cancer using multi-parameter analysis, an international randomized trial of tumor gene expression test-directed chemotherapy treatment in a largely node-positive population.
Rob Stein, Andreas Makris, Iain R. Macpherson, Luke Hughes‐Davies, Andrea Marshall, Georgina Dotchin +13 more
2021· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations
affunlabeled
Molecular bases for sensitivity to figitumumab (CP-751,871) in NSCLC
Antonio Gualberto, Marisa Dolled‐Filhart, Mary L. Hixon, Jared A. Christensen, David L. Rimm, A. V. Lee +4 more
2009· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations
fundno affunlabeled
CAcTUS: A parallel arm, biomarker driven, phase II feasibility trial to determine the role of circulating tumor DNA in guiding a switch between targeted therapy and immune therapy in patients with advanced cutaneous melanoma.
Rebecca Lee, Dominic G. Rothwell, Shien Chow, Heather M. Shaw, Samra Turajlic, Nigel Smith +12 more
2021· article· en· Journal of Clinical Oncology· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
11
citations

How this was built: Screen · Findings · About